Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Marimastat does not meet primary or secondary endpoints in brain cancer trial

June 26, 2000

Potent tricyclic protein farnesyltransferase inhibitors described by Schering-Plough

June 26, 2000

Collaboration to develop CpG DNA-based cancer products

June 26, 2000

Mechanism of apoptosis induction elucidated for NIK-333

June 23, 2000

Daiichi commences development of new anticancer compound

June 23, 2000

New research strengthens link between COX-2 and angiogenesis/tumor growth

June 23, 2000

New guanidino distamycin analogue selected by Pharmacia for clinical development

June 22, 2000

Halimide: a new cytotoxic alkaloid discovered at the University of California

June 22, 2000

Cancer drug resistance may be inhibited by drug for alcoholism

June 22, 2000

Novartis and Modex to research encapsulated protein delivery in cancer therapy

June 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...